The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis

This study aimed to restore the skin barrier function from atopic dermatitis (AD) via treatment with leucine-rich glioma inactivated 3 (LGI3) peptide. Male NC/Nga mice (7 weeks, 20 g) were randomly allocated into three groups (control, AD, and LGI3 group). After induction of AD skin lesions with Der...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ui Seok, Park, Jin Woo, Park, Eon Sub, Bang, Joon Seok, Jung, Tae Woo, Kim, Dong-Seok, Abd El-Aty, A. M., Lee, Jong Hyuk, Jeong, Ji Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463480/
https://www.ncbi.nlm.nih.gov/pubmed/32785038
http://dx.doi.org/10.3390/pharmaceutics12080750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463480/
https://www.ncbi.nlm.nih.gov/pubmed/32785038
http://dx.doi.org/10.3390/pharmaceutics12080750

Ejemplares similares